Hot Alert: Opko Health, Inc. (NYSE:OPK), Adaptimmune Therapeutics plc (NASDAQ:ADAP), Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), Trustmark Corporation (NASDAQ:TRMK), Cascade Microtech Inc. (NASDAQ:CSCD)

Opko Health, Inc. (NYSE:OPK) belongs to Healthcare sector. Its weekly performance is -0.42%. On last trading day company shares ended up $16.74. Opko Health, Inc. (NYSE:OPK) distance from 50-day simple moving average (SMA50) is 3.44%. OPKO Health, Inc., (NYSE:OPK) has completed enrollment in the single pivotal phase 3 trial of its long acting human growth hormone (hGH-CTP) in growth hormone deficient (GHD) adults.

Adaptimmune Therapeutics plc (NASDAQ:ADAP) shares advanced 6.49% in last trading session and ended the day at $17.06. ADAP return on assets is -62.00%. On 2 July, Adaptimmune Therapeutics plc (NASDAQ:ADAP), announced that the U.S. Food and Drug Administration (FDA) has accepted the Company`s investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors (TCRs) specific for MAGE A10 (MAGE-A10 T) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), and that the IND is now active.

On 14 July, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares decreased -0.91% and was closed at $18.56. AEGR EPS growth in last 5 year was 32.10%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) year to date (YTD) performance is -11.37%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) announced that on July 1, 2015, Aegerion granted stock options to purchase an aggregate of 71,700 shares of common stock to 12 new employees under the inducement stock option program.

Trustmark Corporation (NASDAQ:TRMK) ended the last trading day at $25.02. Company weekly volatility is calculated as 1.49% and price to cash ratio as 5.04. Trustmark Corporation (NASDAQ:TRMK) showed a weekly performance of 2.37%. Trustmark Corporation(NASDAQ:TRMK) will announce its second quarter 2015 financial results in a news release on Tuesday, July 28, after close of the market. Gerard R. Host, President and Chief Executive Officer, will conduct a conference call with analysts on Wednesday, July 29 at 10:00 a.m. Central Time to discuss the Corporation’s financial results.

Cascade Microtech Inc. (NASDAQ:CSCD) shares remains unchanged in last trading session and ended the day at $15.13. CSCD Gross Margin is 53.20% and its return on assets is 8.30%. Cascade Microtech Inc. (NASDAQ:CSCD) quarterly performance is 8.77%.Cascade Microtech, Inc. (NASDAQ: CSCD), announced it participated in the Seventh Annual CEO Investor Summit 2015 in San Francisco on Wednesday, July 15, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *